Overview

Clinical Trial on Education Method of Fluterol® Inhalation Inhaler for Asthma Control

Status:
Completed
Trial end date:
2017-05-10
Target enrollment:
Participant gender:
Summary
A multi-center, randomized, open, non-inferiority, Phase 4 study
Phase:
Phase 4
Details
Lead Sponsor:
Hanmi Pharmaceutical Company Limited
Treatments:
Fluticasone
Salmeterol Xinafoate